Remarkably, elevated expression of USP10 in CRC is a strong indicator of overall poor patient survival in CRC (Fig. 1f), especially in the molecular subtypes CMS2-4 (Fig. S1e). This evidence concerns the gene USP10 and colorectal carcinoma.